<?xml version="1.0" encoding="UTF-8"?>
<p>The same goes if you consider that a regulatory marketing authorization is sufficient for interchangeability (due to the diversity of regulatory paths and the possible insufficiency of clinical data submitted before marketing authorizations).</p>
